Bank Of New York Mellon Corp Aspira Women'S Health Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.32 - $0.58 $9,161 - $16,605	28,631 New	28,631 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$0.3 - $0.41 $8,589 - $11,738	28,631 New	28,631 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $77,334 - $210,737	-193,337 Reduced 87.1%	28,631 $17,000
Q4 2021 Feb 11, 2022	SELL	$1.63 - $3.43 $2,792 - $5,875	-1,713 Reduced 0.77%	221,968 $393,000
Q3 2021 Nov 12, 2021	BUY	$3.19 - $5.48 $5,614 - $9,644	1,760 Added 0.79%	223,681 $727,000
Q2 2021 Aug 11, 2021	SELL	$4.78 - $6.84 $19,263 - $27,565	-4,030 Reduced 1.78%	221,921 $1.25 Million
Q1 2021 May 13, 2021	SELL	$5.9 - $9.13 $34,178 - $52,890	-5,793 Reduced 2.5%	225,951 $1.53 Million
Q4 2020 Feb 09, 2021	BUY	$3.0 - $6.71 $143,871 - $321,791	47,957 Added 26.09%	231,744 $1.56 Million
Q3 2020 Nov 12, 2020	BUY	$2.54 - $4.56 $134,068 - $240,690	52,783 Added 40.29%	183,787 $567,000
Q2 2020 Aug 12, 2020	BUY	$0.78 - $5.25 $102,183 - $687,771	131,004 New	131,004 $503,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.